Amgen Inc. (AMG MU) stock market data APIs
€281.9935
0(0%)
as of January 20, 2026
Try our APIs with
free plan!
Amgen Inc. Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for AMG.MU.
Prev. Close
281.9935
Open
281.9935
High
281.9935
Low
281.9935
52 wk Range
227.5082-297.65
Market Cap
105 182 M
EPS
2.17
Dividends (Yield)
0.0221
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Amgen Inc. data using free add-ons & libraries
Get Amgen Inc. Fundamental Data
Amgen Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2018-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Amgen Inc. News
New
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference
Biocom’s Global Partnering & Investor Conference brings together over 500 investors and senior executives, including CEOs and heads of business development, biotech, and research and development fro...
Ember LifeSciences appoints Ann Hyllengren as Chief Financial Officer
Industry veteran to bolster executive leadership team, support company's growth LOS ANGELES, Jan. 21, 2026 /PRNewswire/ -- Following its recent $16.5 million Series A financing in December, Ember Lif...
Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies
Amgen Inc. (NASDAQ:AMGN) is one of the best undervalued wide moat stocks.Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies A dose bottle of the medication is in the medic...
Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.52
The board of Amgen Inc. (NASDAQ:AMGN) has announced that it will be paying its dividend of $2.52 on the 6th of March, an increased payment from last year's comparable dividend. The payment will take t...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
